325 related articles for article (PubMed ID: 17371346)
1. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
[TBL] [Abstract][Full Text] [Related]
2. More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.
Kusaba T; Konno Y; Hatta S; Fujino T; Yasuda T; Miura H; Sasaki H; Okabayashi J; Murao M; Sakurada T; Imai G; Shirai S; Kuboshima S; Shima Y; Ogimoto G; Sato T; Masuhara K; Kimura K
Pharmacotherapy; 2005 Jan; 25(1):52-8. PubMed ID: 15767220
[TBL] [Abstract][Full Text] [Related]
3. Preprandial vs. postprandial pharmacokinetics of cyclosporine in patients with psoriasis.
Umezawa Y; Mabuchi T; Ozawa A
Int J Dermatol; 2007 Aug; 46(8):880-2. PubMed ID: 17651179
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome.
Naito M; Takei T; Eguchi A; Uchida K; Tsuchiya K; Nitta K
Intern Med; 2008; 47(18):1567-72. PubMed ID: 18797114
[TBL] [Abstract][Full Text] [Related]
5. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
7. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
9. Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis.
Umezawa Y; Ozawa A
Int J Dermatol; 2007 Jul; 46(7):763-6. PubMed ID: 17614813
[TBL] [Abstract][Full Text] [Related]
10. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
Kaplan B; Meier-Kriesche HU; Napoli KL; Kahan BD
Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
[TBL] [Abstract][Full Text] [Related]
13. Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome.
Shirai S; Yasuda T; Tsuchida H; Kuboshima S; Konno Y; Shima Y; Sato T; Hatta S; Masuhara K; Kimura K
Clin Exp Nephrol; 2009 Apr; 13(2):123-129. PubMed ID: 19057979
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[TBL] [Abstract][Full Text] [Related]
15. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Bunnag S; Vareesangthip K; Ong-ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
[TBL] [Abstract][Full Text] [Related]
17. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
18. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
19. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B
Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
[TBL] [Abstract][Full Text] [Related]
20. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients.
Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C
Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
